# US 2013/0252243 A1 · Methods of determining potency of chemically-synthesized oligonucleotides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0252243 A1
- Document ID: US20130252243A1
- Status: Published application
- Kind: A1
- Application number: 13/724,825
- Filed: 2012-12-21
- Published: 2013-09-26
- Earliest claimed: 2006-10-18
- Assignees: Isis Pharmaceuticals, Inc.
- Applicants: Isis Pharmaceuticals, Inc.
- Inventors: Walter F. Lima; Timothy Vickers; Stanley T. Crooke
- Web page: https://patentgrep.com/patent/US20130252243A1

## CPC

- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- C12N 2310/11: Antisense
- C12N 2310/14: interfering nucleic acids [NA]
- C12N 2320/10: in screening processes
- Y10T 436/143333: Saccharide [e.g., DNA, etc.]
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

Provided herein are methods for determining potency of RNAi agents. Such methods include, but are not limited to, cell-based and cell-free assays that measure binding of an RNAi agent with Ago2 or that measure Ago2 activity in the presence of such RNAi agents. Also provided are assays that determine potency of RNAi agents by assessing their ability to compete with other RNAi agents, including control RNAi agents, for binding and/or activation of Ago2.

## Claims

### Claim 1

A method of determining relative potency of a chemically-synthesized RNAi agent comprising:
forming a first test sample comprising the chemically-synthesized RNAi agent and Ago2;
forming a second test sample comprising an RNAi control agent and Ago2; and
measuring the Ago2 activity of the chemically-synthesized RNAi agent and the Ago2 activity of the RNAi control agent, wherein the difference in the Ago2 activity of the chemically-synthesized RNAi agent and Ago2 activity of the control RNAi agent indicates potency of the chemically-synthesized RNAi agent relative to the control RNAi agent.

### Claim 2 (depends on 1)

The method of claim 1, wherein the Ago2 is recombinant.

### Claim 3 (depends on 1)

The method of claim 1, wherein the Ago2 is obtained by immunoprecipitation from a cell.

### Claim 4 (depends on 2)

The method of claim 2, wherein the cell is made to over-express the Ago2 protein.

### Claim 5 (depends on 1)

The method of claim 1, wherein the degree of binding is measured by measuring an amount of chemically-synthesized RNAi agent bound to the Ago2.

### Claim 6 (depends on 1)

The method of claim 1, wherein the chemically-synthesized RNAi agent is an oligonucleotide.

### Claim 7 (depends on 6)

The method of claim 6, wherein the oligonucleotide is from about 15 to about 27 nucleotides in length.

### Claim 8 (depends on 6)

The method of claim 6, wherein the oligonucleotide comprises a complementary strand from about 15 to about 27 nucleotides in length.

### Claim 9 (depends on 6)

The method of claim 6, wherein the oligonucleotide is an antisense oligoribonucleotide.

### Claim 10 (depends on 6)

The method of claim 6, wherein the oligonucleotide comprises at least one sugar-modified nucleotide.

### Claim 11 (depends on 10)

The method of claim 10, wherein the sugar-modified nucleotide is a 2′ substituted nucleotide.

### Claim 12 (depends on 6)

The method of claim 6, wherein the oligonucleotide comprises at least one modified internucleoside linkage.

### Claim 13 (depends on 12)

The method of claim 12, wherein the modified internucleoside linkage is a phosphorothioate internucleoside linkage.
